Washington Attorney General Nick Brown joined a bipartisan coalition of 43 states and territories in seeking federal court approval for a 400 million dollar settlement with generic pharmaceutical manufacturers Sandoz Inc. and Fougera Pharmaceuticals Inc.
According to legal filings published by the Washington State Office of the Attorney General , Sandoz agreed to comprehensive injunctive terms without admitting liability, establishing mandatory internal governance reforms to ensure strict adherence to federal and state antitrust statutes.
Collusive Market Allocation Targeted Everyday Generic Prescriptions The core factual allegations underpinning the state litigation center on an anti-competitive industry practice known among pharmaceutical executives as fair share market allocation.
State attorneys general subsequently raised legal claims alleging that the corporate separation constituted a fraudulent transfer intended to insulate parent company assets from catastrophic antitrust liabilities accumulated during Sandoz's tenure as a subsidiary.
Restitution payments will be calculated based on the volume and category of qualifying generic drugs purchased, providing financial relief directly to households that bore the financial burden of manipulated prescription prices.
Washington Attorney General Nick Brown joins 43 states in a $400M settlement with Sandoz and Fougera over generic drug price fixing, securing over $12M for Washington alongside dedicated restitution for local businesses.